37 results
8-K
EX-2.1
AKLI
Akili Inc
29 May 24
Entry into a Material Definitive Agreement
9:14am
; Compliance.
SECTION 4.22 Insurance.
SECTION 4.23 Anti-Corruption; Global Trade Control Laws.
SECTION 4.24 Suppliers.
SECTION 4.25 Brokers and Finder’s Fees … subsidiaries has been questioned, denied or disputed.
SECTION 4.23 Anti-Corruption; Global Trade Control Laws.
(a) In the past five years, neither
424B3
AKLI
Akili Inc
10 Aug 23
Prospectus supplement
4:17pm
of which could adversely affect our business. For example, the loss, corruption, unavailability of, or damage to our computational models would … . In addition, the loss or corruption of, or other damage to, clinical trial data from ongoing or future clinical trials could result in delays in our
424B3
f045epmtf8da626iazgn
12 May 23
Prospectus supplement
8:34am
424B3
46wjhs
14 Nov 22
Prospectus supplement
4:11pm
424B3
msbde 4mf73piu9
17 Oct 22
Prospectus supplement
4:37pm
8-K
jyu5s1vngu
23 Aug 22
Index to Financial Statements
4:45pm
8-K
EX-14.1
1nilq1vwgrq84wquthy
23 Aug 22
Index to Financial Statements
4:45pm
DEFM14A
1twlkm0tcboskt
21 Jul 22
Proxy related to merger
5:18pm
424B3
2udypca6e7
21 Jul 22
Prospectus supplement
5:16pm